Aclaris to Present at 35th Annual J.P. Morgan Healthcare Conference
January 03 2017 - 8:00AM
Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led
clinical-stage pharmaceutical company focused on defining new
standards of care in medical and aesthetic dermatology, today
announced that it plans to present at the 35th Annual J.P. Morgan
Healthcare Conference. Aclaris President and Chief Executive
Officer Dr. Neal Walker will present on Wednesday, January 11,
2016 at 3:30 pm PT (6:30 pm ET) at The Westin St. Francis in San
Francisco.
A live audio webcast of the presentation will be available on
the Investors section of the company's website, www.aclaristx.com.
A replay will be available after the event.
About Aclaris Therapeutics, Inc.Aclaris
Therapeutics, Inc. is a clinical-stage dermatologist-led
pharmaceutical company focused on identifying, developing and
commercializing innovative and differentiated therapies to address
significant unmet needs in medical and aesthetic dermatology.
Aclaris is based in Malvern, Pennsylvania.
Contact:
Aclaris Contact
Michael Tung, M.D.
Investor Relations
484-329-2140
mtung@aclaristx.com
Media Contact
Mariann Caprino
TogoRun
917-242-1087
M.Caprino@togorun.com
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Apr 2023 to Apr 2024